New statins and new doses of older statins.

被引：20

作者：

Stein E.A. ^{[1
]}

机构：

[1] Medical Research Laboratories, Highland Heights, 2 Tesseneer, 41076, KY

来源：

Current Atherosclerosis Reports | 2001年 / 3卷 / 1期

关键词：

Statin; Simvastatin; Atorvastatin; Fenofibrate; Rosuvastatin;

D O I：

10.1007/s11883-001-0005-z

中图分类号：

学科分类号：

摘要：

The need for greater reductions in LDL cholesterol, although remaining to be proven as clinically beneficial, continues to drive the development of either higher doses of currently approved and marketed statins or the development of new, more effective agents.

引用

页码：14 / 18

页数：4

共 32 条

[1]

Olsson AG(2000)Pharmacodynamics of a new HMG CoA reductase inhibitor ZD 4522 in patients with primary hypercholesterolemia [abstract] Atherosclerosis 151 38-38

[2]

Pears JS(2000)Pharmacological properties of ZD 4522—a new HMG CoA reductase inhibitor [abstract] Atherosclerosis 151 38-38

[3]

McKellar J(2000)Uptake of HMG-CoA reductase inhibitor ZD4522 into hepatocytes and distribution into liver and other tissues of the rat [abstract] Atherosclerosis 151 38-38

[4]

Smith G(2000)Selectivity of ZD4522 for inhibition of cholesterol synthesis in hepatic versus non-hepatic cells [abstract] Atherosclerosis 151 41-41

[5]

Davidson R(2000)Clinical evaluation of NK-104 (itavastatin) in long-term treatment of patients with hyperlipidemia [abstract] Atherosclerosis 53 W6-68

[6]

Bloor S(2000)Efficacy and safety of cerivastatin 0.8 mg in patients with hypercholesterolaemia: the pivotal placebo-controlled clinical trial J Int Med Res 28 47-203

[7]

Nezasa K(2000)Fluvastatin extended-release formulation is effective in treating primary hypercholesterlaemia [abstract] Atherosclerosis 52 W6-42

[8]

Higaki K(2000)A pilot study with simvastatin and folic acid/vitamin B12 in preparation for the study of the effectiveness of additional reductions in cholesterol and homocysteine (SEARCH) Nutr Metab Cardiovasc Dis 10 195-107

[9]

Hasegawa H(1997)The efficacy and six-week tolerability of simvastatin 80 and 160 mg/day Am J Cardiol 79 38-1436

[10]

Buckett L(1997)The rule of 5 and the rule of 7 in lipid-lowering by statin drugs Am J Cardiol 80 106-undefined

← 1 2 3 4 →